Physician profile
Neeta Tripathi
NPI 1164492385
$3,853.06
in general payments reported to CMS, 2019-2025
20 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $215 · 2020: $444 · 2021: $313 · 2022: $157 · 2023: $2,046 · 2024: $284 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395 · Travel and Lodging: $1,329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.79 |
| Travel and Lodging | $1,329.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,130.59 | 2020-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Boston Scientific Corporation | $397.98 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| Janssen Pharmaceuticals, INC | $321.28 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $185.14 | 2019-2022 | |
| Amgen INC. | $121.41 | 2019-2021 | |
| Pfizer INC. | $119.53 | 2020-2024 | |
| E.R. Squibb & Sons, L.L.C. | $110.25 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $90.82 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.48 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $53.59 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $43.19 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.82 | 2022-2025 | Jardiance |
| Amarin Pharma, INC. | $28.63 | 2019-2020 | |
| Abiomed | $26.98 | 2023 | Impella |
| Lexicon Pharmaceuticals, INC. | $26.75 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $26.13 | 2021-2022 | |
| Atricure, INC. | $23.08 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.17 | 2025 | Lifevest |
| Bridgebio Pharma, INC. | $16.27 | 2025 | Attruby |
| Novo Nordisk INC | $14.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neeta Tripathi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.